CTLA4 and neoplasm: Another outstanding finding was the induction of systemic antitumor response after intratumor Treg depletion with a mAb targeting CTLA-4 molecule, underscoring the relevance of Tregs as immunosuppressive mechanisms in tumor settings (22).